Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours Β· Estimated delivery Aug 27 - Sep 1
A total of 1407 randomized adults, with a mean baseline body weight of 113 kg, were randomized to once-weekly semaglutide 7.2 mg, semaglutide 2.4 mg, or placebo over 72 weeks, in conjunction with lifestyle intervention
Protocols are personalized with precise dosing, careful timing, and ongoing physician oversight
Semaglutide is a synthetic, long-acting analog of human glucagon-like peptide-1 designed for GLP-1 receptor research
If necessary, they can be kept at room temperature (below 30C) for up to 28 days
The most common injectable dose for research purposes appears to be 1-2 mg per day over a thirty-day treatment course
US$ 21.09
US$ 26.34
US$ 21.63
US$ 22.63
US$ 27.12
US$ 23.41
